NSPR - InspireMD, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
3,360
3,601
2,761
1,894
2,310
Cost of Revenue
2,566
2,606
2,176
1,792
2,606
Gross Profit
794
995
585
102
-296
Operating Expenses
Research Development
3,043
1,535
1,276
1,291
3,642
Selling General and Administrative
7,249
7,071
7,541
6,459
9,565
Total Operating Expenses
10,292
8,606
8,817
7,750
13,207
Operating Income or Loss
-9,498
-7,611
-8,232
-7,648
-13,503
Interest Expense
-
-
179
812
1,036
Total Other Income/Expenses Net
-
-
-
-812
-982
Income Before Tax
-9,637
-7,240
-8,411
-8,460
-15,581
Income Tax Expense
0
0
27
1
4
Income from Continuing Operations
-9,637
-7,240
-8,438
-8,461
-15,585
Net Income
-9,637
-7,240
-8,438
-8,461
-15,585
Net Income available to common shareholders
-10,093
-7,696
-13,028
-8,461
-15,585
Reported EPS
Basic
-
-16.50
-1.75k
-10.04k
-89.06k
Diluted
-
-16.50
-1.75k
-10.04k
-89.06k
Weighted average shares outstanding
Basic
-
462
7
1
0
Diluted
-
462
7
1
0
EBITDA
-
-7,611
-8,232
-7,648
-13,503